Effects of Caryota mitis profilin-loaded PLGA nanoparticles in a murine model of allergic asthma

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 4553-4562

  Xiao, Xiaojun ^a   Zeng, Xiaowei ^b   Zhang, Xinxin ^c   Ma, Li ^c   Liu, Xiaoyu ^a   Yu, Haiqiong ^a   Mei, Lin ^b,d   Liu, Zhigang ^a  

^a Shenzhen University   (China)

^b TSINGHUA UNIVERSITY   (China)

^c NANCHANG UNIVERSITY   (China)

^d Xili University Town   (China)

Author keywords

Adjuvant; Allergic asthma; Caryota mitis profilin; Nanoparticles; PLGA

Indexed keywords

CARYOTA MITIS PROFILIN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; NANOPARTICLE; POLYGLACTIN; PROFILIN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ALLERGIC ASTHMA; ARTICLE; CELLULAR IMMUNITY; CYTOKINE RELEASE; DISEASE MODEL; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; IMMUNOTHERAPY; LUNG PARENCHYMA; PROTEIN BLOOD LEVEL; RESPIRATORY TRACT ALLERGY; TH1 CELL; TH2 CELL;

AMBROSIA; ARECACEAE; CARYOTA MITIS; MURINAE;

ADJUVANT; ALLERGIC ASTHMA; CARYOTA MITIS PROFILIN; NANOPARTICLES; PLGA;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ARECACEAE; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LACTIC ACID; LUNG; MICE; MICE, INBRED BALB C; NANOPARTICLES; PARTICLE SIZE; PLANT PROTEINS; POLLEN; POLYGLYCOLIC ACID; PROFILINS; RECOMBINANT PROTEINS; RESPIRATORY HYPERSENSITIVITY;

EID: 84888343277     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S51633     Document Type: Article

References (36)

1. Theodoropoulos DS, Lockey RF. Allergen immunotherapy: guidelines, update, and recommendations of the World Health Organization. Allergy Asthma Proc. 2000;21(3):159-166.
2. Traidl-Hoffmann C, Kasche A, Menzel A, et al. Impact of pollen on human health: more than allergen carriers. Allergy Immunol. 2003;131(1): 1-13.
3. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5):S148-S217.
4. Passalacqua G, Canonica GW. Sublingual immunotherapy: update 2006. Curr Opin Allergy Clin Immunol. 2006;6(6):449-454.
5. Lue KH, Lin YH, Sun HL, Lu KH, Hsieh JC, Chou MC. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study. Pediatr Allergy Immunol. 2006;17(6):408-415.
6. Ebner C, Siemann U, Bohle B, et al. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from Th2 to Th1 in T-cell clones specific for Ph1 p 1, a major grass pollen allergen. Clin Exp Allergy. 1997;27(9): 1007-1015.
7. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4 T cells from allergic individuals. J Exp Med. 1993;178(6):2123-2130.
8. Beusquet J, Lockey R, Malling HJ. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. J Allergy Clin Immunol. 1998;102(4 Pt 1):558-562.
9. Peek LJ, Middaugh CR, Berkland C. Nanotechnology in vaccine delivery. Adv Drug Deliv Rev. 2008;60(8):915-928.
10. Zhang Z, Guo Y, Feng SS. Nanoimmunotherapy: application of nanotechnology for sustained and targeted delivery of antigens to dendritic cells. Nanomedicine. 2012;7(1):1-4.
11. Hong Z, Zhang P, Liu A, Chen L, Chen X, Jing X. Composites of poly(lactide-co-glycolide) and the surface modified carbonated hydroxyapatite nanoparticles. J Biomed Mater Res. 2007;81(3):515-522.
12. Dinarvand R, Sepehri N, Manoochehri S, Rouhani H, Atyabi F. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine. 2011;6:877-895.
13. Klose D, Siepmann F, Elkharraz K, Siepmann J. PLGA-based drug delivery systems: importance of the type of drug and device geometry. Int J Pharm. 2008;354(1-2):95-103.
14. Dorozhkin SV. Calcium orthophosphate based biocomposites and hybrid materials. J Mater Sci. 2009;44(9):2343-2387.
15. Ren J, Zhao P, Ren T, Gu S, Pan K. Poly (D, L-lactide)/nano-hydroxyapatite composite scaffolds for bone tissue engineering and biocompatibility evaluation. J Mater Sci Mater Med. 2008;19(3): 1075-1082.
16. Scholl I, Weissenbock A, Forster-Waldl E, et al. Allergen-loaded biodegradable poly(D, L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model. Clin Exp Allergy. 2004;34(2):315-321.
17. Santos A, Van Ree R. Profilins: mimickers of allergy or relevant allergens? Int Arch Allergy Immunol. 2011;155(3):191-204.
18. Liu XY, Wu YL, Liu ZG, Meng G, Zhang HY. Cloning, expression and immunocharacterization of panallergen profilin from Caryota mitis pollen. J Trop Med. 2007;7(7):618-622.
19. Jain AK, Goyal AK, Gupta PN, et al. Synthesis, characterization and evaluation of novel triblock copolymer based nanoparticles for vaccine delivery against hepatitis B. J Control Release. 2009;136(2): 161-169.
20. Buske J, König C, Bassarab S, Lamprecht A, Mühlau S, Wagner KG. Influence of PEG in PEG-PLGA microspheres on particle properties and protein release. Eur J Pharm Biopharm. 2012;81(1):57-63.
21. Yu HQ, Li XH, Liu ZG, et al. Sublingual immunotherapy efficacy of Dermatophagoides farinae vaccine in a murine asthma model. Int Arch Allergy Immunol. 2009;152(1):41-48.
22. Winkler B, Baier K, Wagner S, et al. Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. Clin Exp Allergy. 2002;32(1):30-36.
23. Lu M, Dawicki W, Zhang X, Huang H, Nayyar A, Gordon JR. Therapeutic induction of tolerance by IL-10-differentiated dendritic cells in a mouse model of house dust mite-asthma. Allergy. 2011;66(5): 612-620.
24. Marazuela EG, Rodríguez R, Barber D, Villalba M, Batanero E. Hypoallergenic mutants of Ole e 1, the major olive pollen allergen, as candidates for allergy vaccines candidates for allergy vaccines. Clin Exp Allergy. 2007;37(2):251-260.
25. Florence AT. Nanoparticle uptake by the oral route: fulfilling its potential? Drug Discov Today Technol. 2005;2(1):75-81.
26. Yan F, Zhang C, Zheng Y, et al. The effect of Poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomedicine. 2010;6(1):170-178.
27. Huang LQ, Chen H, Zheng Y, et al. Nanoformulation of D-a-tocopheryl polyethylene glycol 1000 succinate-b-poly (ε-caprolactone-ran-glycolide) diblock copolymer for breast cancer therapy. Integr Biol (Camb). 2011;3(10):993-1002.
28. Roitt I, Brostoff J, Male D. Immunology. 5th ed. Philadelphia, PA: Mosby; 1998.
29. Vieths S, Scheurer S, Ballmer-Weber B. Current understanding of cross-reactivity of food allergens and pollen. Ann N Y Acad Sci. 2002;964: 47-68.
30. Meng G, Li C, Cai Q, Xie C. Survey on pollen sensitization of tropic plants in Haikou. J Clin Otorhinolaryngol (China). 2005;19(22):1044-1045. Chinese.
31. Martínez-Gómez JM, Johansen P, Erdmann I, Senti G, Crameri R, Kündig TM. Intralymphatic injections as a new administration route for allergen-specific immunotherapy. Int Arch Allergy Immunol. 2009;150(1):59-65.
32. Mohaghegh M, Tafaghodi M. Dextran microspheres could enhance immune responses against PLGA nanospheres encapsulated with tetanus toxoid and Quillajasaponins after nasal immunization in rabbit. Pharm Dev Technol. 2011;16(1):36-43.
33. Schnieders J, Gbureck U, Thull R, Kissel T. Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials. 2006;27(23):4239-4249.
34. Zhao K, Li GX, Jin YY, et al. Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres. J Microencapsul. 2010;27(2):178-186.
35. Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J Control Release. 2011;153(2):106-116.
36. Kalkanidis M, Pietersz GA, Xiang SD, et al. Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity. Methods. 2006;40(1):20-29.